CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
CNBX Pharmaceuticals Employees
CNBX Pharmaceuticals had 2 employees as of August 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$20,319
Profits / Employee
-$275,514
Market Cap
280.00K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
CNBX Pharmaceuticals News
- 2 years ago - Cannabis REITs: Smoked Out - Seeking Alpha
- 2 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
- 2 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
- 2 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
- 2 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
- 2 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
- 2 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
- 3 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire